Compounds > indirubin-3'-monoxime
Page last updated: 2024-10-29

indirubin-3'-monoxime and Tuberculosis

indirubin-3'-monoxime has been researched along with Tuberculosis in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toossi, Z1
Wu, M1
Hirsch, CS1
Mayanja-Kizza, H1
Baseke, J1
Aung, H1
Canaday, DH1
Fujinaga, K1

Other Studies

1 other study available for indirubin-3'-monoxime and Tuberculosis

ArticleYear
Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:2

    Topics: Adult; Blotting, Western; Coinfection; Cyclin T; Female; HIV Infections; HIV-1; Humans; Indoles; Mal

2012